Option chain shows key data for HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd.

HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd (OTC:HBGHF) Stock, Option Chain

HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd

Benchmark analyst Subash Chandra reiterates Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Buy and maintains $93 price target.

News

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Expand Energy, Maintains $93 Price Target

Former Palo Alto Networks CEO brings extensive technology and security experience to Blaize
Blaize Holdings, Inc. ("Blaize") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>), a provider of purpose-built, artificial intelligence ("AI")-enabled edge computing solutions, today announced the appointment of technology executive and investor Lane Bess as chairman of its board of directors.
Bess has over 35 years of experience as a successful operational executive, leading startups and helping to build some of the most iconic internet security companies. He is the former CEO of Palo Alto Networks, leading the company to its IPO. Later he played an instrumental role in leading Zscaler to its IPO. He also has held key positions in major companies such as Trend Micro Internet Security, NCR Corporation and AT&amp;T. His considerable work in the security technology sector has made him a trusted advisor for many enterprise technology CIOs and CISOs.
Lane's relationship with Blaize began more than three years ago when he became a key Blaize investor based on his conviction in semiconductor AI technology at the edge and his recognition of the significant potential of this emerging market.

Management

BZAI

Blaize Holdings Appoints Lane Bess As Chairman Of Its Board Of Directors

Gov. <a href="https://www.benzinga.com/real-estate/24/04/38046445/florida-governor-ron-desantis-raises-alarm-by-calling-citizens-insurance-not-solvent-as-an-explosive">Ron DeSantis</a> has a new pitch for Florida: bring NASA headquarters to the Sunshine State. Speaking at the Kennedy Space Center, he laid out a case that's as bold as practical. According to DeSantis, Washington D.C. isn't the right home for NASA anymore. Florida is.
"They have this massive building in D.C. and like nobody goes to it," DeSantis said in his signature direct style. His argument? NASA belongs where the action is – on Florida's Space Coast. "Why not just shutter it and move everyone down here?"
It's not just about geography. Florida is already a powerhouse in the aerospace industry. With 150,000 aerospace workers, three active spaceports and billions flowing into the state's economy, DeSantis says it's the logical next step.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks-y2">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>
"Hopefully, with the new administration coming in, they'll see a great opportunity to headquarter NASA on the Space Coast," he added, pointing out that Florida is home to the busiest spaceport in the world.
Rob Long, CEO of Space Florida, echoed that sentiment, saying Florida has the workforce, infrastructure and leadership to handle the nation's most <a href="https://www.benzinga.com/startups/24/12/42496960/elon-musk-tried-to-create-a-new-intergalactic-media-empire-called-thud-he-offered-2-million-to-onion-editors-and-poached-staff-away">important space operations</a>. "It makes logical sense to me to take the headquarters of the nation's space agency and put it in the state that is already leading across the space industry in general and in research and in talent," Long said.
But not everyone is sold on the idea. According to a CBS News article, Dr. Ken Kremer, a research scientist and editor of Space Up Close, warned that centralizing NASA in Florida could have long-term downsides. "It's bad policy for the public and it is bad politically," Kremer said. He explained that NASA's location in Washington ensures funding and political support from leaders nationwide. "If they concentrate everything in Florida, no one else will care."
See Also: Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
DeSantis didn't dive into specifics like a timeline or legislative plans, but his push to relocate NASA fits into Florida's broader efforts to dominate the space industry. Universities like the University of Florida, University of Central Florida and Embry-Riddle have already teamed up with the Kennedy Space Center to create the Florida University Space Research Consortium, which positions the state as a leader in space research grants.
Whether or not NASA makes the move, DeSantis's pitch underscores Florida's <a href="https://www.benzinga.com/real-estate/24/12/42716127/slapping-lipstick-on-a-pig-investors-are-snatching-up-hurricane-damaged-homes-in-florida-to-flip-but-concerns-rise-over-repair-quality">growing role in the space economy</a>. Space Florida estimates the state generates $1.1 billion annually from aerospace activities. For DeSantis, that's just the beginning.
So, while the nation debates the merits of moving NASA, the governor's message is simple: Florida's ready to launch.
Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.
<h2 class="wp-block-heading">Interest Rates Are Falling, But These Yields Aren't Going Anywhere</h2>
Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities.
<a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, <a href="https://www.benzinga.com/go/arrived-private-credit-yf">this one has a minimum investment of only $100.&nbsp;</a>
Looking for fractional real estate investment opportunities? The <a href="https://www.benzinga.com/alternative-investments/real-estate">Benzinga Real Estate Screener</a> features the latest offerings.

Real Estate

'Move Everyone Down Here' – Gov. Ron DeSantis Suggests Moving NASA From Washington D.C. To Florida Since 'Nobody Goes To It'

Macro Economic Events

Econ #s

Economics

CPI MoM For Dec. 0.4% Vs 0.4% Expected; 0.3% Prior

Macro Notification

General

US CPI (YoY) (Dec) +2.9% vs +2.9% Est.; +2.7% Prior

USA Core CPI (MoM) For Dec. 0.2% Vs 0.3% Est.; 0.3% Prior

USA Core CPI (YoY) For December 3.2% Vs 3.3% Est.; 3.3% Prior

Benchmark analyst Christopher Kuhn maintains XPO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) with a Buy and raises the price target from $150 to $155.

Benchmark Maintains Buy on XPO, Raises Price Target to $155

N2OFF, Inc.\ (NASDAQ:<a href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) (FSE:80W) ("N2OFF" and the "Company"), a clean tech company engaged in sustainable solutions for energy and agri-tech innovation, announced that its subsidiary Save Foods Ltd. ("Save Foods") was informed that opposition to its European patent EP2615932 filed by ECOLAB Inc. has been concluded in Save Foods' favor.
ECOLAB Inc. has the right to appeal this decision to the European Patent Register in by April 9, 2025.
The European patent covers a method of protecting edible matter using a specific performic acid composition, which is a significant part of Save Foods' proprietary technology and line of commercial solutions. Save Foods' commercial solutions are proven to extend shelf life of fresh produce while dramatically reducing, by at least 50%, the amount of hazardous pesticides.

Legal

Global

NITO

N2OFF Was Informed That Opposition To Its European Patent EP2615932 Filed By ECOLAB Inc. Has Been Concluded In Save Foods' Favor; ECOLAB Inc. Has The Right To Appeal This Decision To The European Patent Register In By April 9, 2025.

JP Morgan analyst Ann Duignan maintains AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) with a Overweight and raises the price target from $102 to $111.

AGCO

JP Morgan Maintains Overweight on AGCO, Raises Price Target to $111

WIIM

EYEN

Eyenovia shares are trading lower after the company announced that Institutional Shareholder Services and Glass Lewis & Co recommended that stockholders vote in favor of a proposed reverse stock split between 1-for-40 and 1-for-80.

B of A Securities analyst Jason Gerberry maintains Immunovant (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMVT#NASDAQ">IMVT</a>) with a Buy and lowers the price target from $48 to $45.

IMVT

B of A Securities Maintains Buy on Immunovant, Lowers Price Target to $45

Eyenovia, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) ("Eyenovia" or the "Company"), an ophthalmic technology company, today announced that the two leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and Glass Lewis &amp; Co. ("Glass Lewis"), have recommended that Eyenovia stockholders entitled to vote at the Company's 2025 Special Meeting of Stockholders (the "Special Meeting") vote "FOR" the proposed amendment to the Eyenovia, Inc. Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company's issued and outstanding shares of common stock, $0.0001 par value per share, at a ratio of between 1:40 and 1:80.
The reverse stock split will be considered among four proposed items at the upcoming Special Meeting:
<ol>
<li>To approve a proposed amendment to the Eyenovia, Inc. Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 1:40 and 1:80 (the "Reverse Stock Split Amendment");</li>
<li>To approve an amendment to the Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan to reserve an additional 350,000 shares of common stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved;</li>
<li>To approve, for purposes of Nasdaq Listing Rule 5635(d), the potential issuance of up to an aggregate of 73,029,273 shares of the Company's common stock upon the exercise of certain outstanding warrant; and</li>
<li>To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1, 2 or 3.</li>
</ol>

Stock Split

Eyenovia Announces Leading Proxy Advisory Firms, ISS And Glass Lewis, Recommend Eyenovia Stockholders Vote "FOR" Proposed Reverse Stock Split Between 1-For-40 And 1-For-80 At Upcoming Special Meeting of Stockholders

Earnings

BMRA

Biomerica Q2 2025 Revenue $1.64M Vs $1.57M YoY; EPS $(0.06) Vs $(0.09) YoY

B of A Securities analyst Jason Haas maintains Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) with a Buy and raises the price target from $187 to $192.

BOOT

B of A Securities Maintains Buy on Boot Barn Holdings, Raises Price Target to $192

MarketWise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTW#NASDAQ">MKTW</a>) ("MarketWise" or the "Company"), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported preliminary selected unaudited financial and operational updates for fourth quarter 2024 below. Our objective is to provide investors with selected information on recent directional trends in advance of issuing our usual earnings press release announcing full year 2024 financial results, which we expect to release in March 2025.
The selected unaudited results in this press release are preliminary and subject to the Company's normal quarter and year-end accounting procedures and external audit by the Company's independent registered public accounting firm. Therefore, these preliminary unaudited results are subject to adjustment. In addition, these preliminary unaudited results are not a comprehensive statement of the Company's financial results for the year ended December 31, 2024 and should not be viewed as a substitute for full, audited financial statements prepared in accordance with generally accepted accounting principles.
Q4 2024 Preliminary Selected Unaudited Financial and Operational Updates:
<ul>
<li>Consolidated Paid subscribers at December 31, 2024 were 506 thousand. Active Free subscribers were 3.3 million at December 31, 2024.</li>
<li>Billings for Q4 2024 totaled approximately $55 million, representing over a 10% sequential increase compared with Q3 2024.</li>
<li>The estimated increase in Billings in Q4, coupled with the benefits from operational efficiency initiatives, would result in a return to positive cash flow generation for the quarter, following three quarters of negative cash flow.</li>
<li>Cash and cash equivalents balance is estimated to have increased from $94 million at September 30, 2024 to $98 million at December 31, 2024.</li>
<li>The Company also announced a special dividend to shareholders of Class A common stock of $0.03 per share. The dividend which totals approximately $1.3 million in the aggregate, will be paid on February 26, 2025, to shareholders of record as of January 29, 2025.</li>
</ul>

Guidance

Dividends

MKTW

MarketWise Preliminary Q4 2024 Update: 506K Paid Subscribers, 3.3M Active Free Subscribers, $55M Billings Increase Over 10% From Q3 2024, Cash Balance Up To $98M; Declares $0.03/Share Special Dividend To Be Paid February 26, 2025.

QBTS

D-Wave Quantum shares are trading higher after the company announced a partnership with Carahsoft to expand the distribution of quantum computing solutions to the public sector.

RPID

Rapid Micro Biosystems shares are trading higher after the company reported better-than-expected preliminary Q4 revenue results.

Biomerica shares are trading higher. The company reported Q2 financial results.

Wells Fargo analyst Hanwen Chang maintains Vital Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTLE#NYSE">VTLE</a>) with a Equal-Weight and raises the price target from $34 to $36.

Comments

HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd

HONBRIDGE HOLDINGS LTD by Honbridge Holdings Ltd (HBGHF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga